Oxybuprocaine Hydrochloride

盐酸奥布卡因

Report date: 2024/06/18 17:34:30

Base Information

Drug NameOxybuprocaine Hydrochloride
Drug Alias Name盐酸丁氧普鲁卡因oxybuprocainumBenoxinate HydrochlorideNovesineNovesin +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsLacrimal Apparatus DiseasesAnesthesia
Global Approved IndicationsLacrimal Apparatus DiseasesAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLacrimal Apparatus DiseasesAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeD04AB03S01HA02